To examine whether @ weeks of treatment with a dipeptidyl peptidase-@ ( DPP-@ ) inhibitor , sitagliptin , influences the insulin secretion induced by glucose , glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-@ ( GLP-@ ) during a hyperglycaemic clamp in patients with type @ diabetes ( T@DM ) .